(Q44203598)

30 November 2017

title

Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery (English)

1 reference

30 November 2017

1 reference

Christopher N Ta

1

1 reference

30 November 2017

Peter R Egbert

2

1 reference

30 November 2017

Kuldev Singh

3

1 reference

30 November 2017

Erin M Shriver

4

1 reference

30 November 2017

Mark S Blumenkranz

5

1 reference

30 November 2017

Herminia Miño De Kaspar

6

1 reference

30 November 2017

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

109

1 reference

30 November 2017

issue

11

1 reference

30 November 2017

page(s)

2036-40; discussion 2040-1

1 reference

Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901236-8

7 January 2021

Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901236-8

7 January 2021

Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901236-8

7 January 2021

Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901236-8

7 January 2021

Outpatient topical use of povidone-iodine in preparing the eye for surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901236-8

7 January 2021

Prophylaxis of Endophthalmitis with Topical Povidone-iodine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901236-8

7 January 2021

[Preoperative infection prophylaxis with 1% polyvidon-iodine solution based on the example of conjunctival staphylococci]

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901236-8

7 January 2021

Effect of topical ciprofloxacin 0.3% and ofloxacin 0.3% on the reduction of bacterial flora on the human conjunctiva

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901236-8

7 January 2021

Bactericidal activity and toxicity of iodine-containing solutions in wounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901236-8

7 January 2021

In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901236-8

7 January 2021

An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901236-8

7 January 2021

10.1016/S0161-6420(02)01236-8

Identifiers

DOI

1 reference

30 November 2017

1 reference